Bayer strengthens pharma portfolio with new cardiology drug acoramidis
Acquisition of exclusive commercialization rights for European markets
Acquisition of exclusive commercialization rights for European markets
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Subscribe To Our Newsletter & Stay Updated